IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 213 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $554,000 | -9.5% | 53,485 | +0.8% | 0.02% | +17.6% |
| Q2 2022 | $612,000 | -27.7% | 53,036 | -21.2% | 0.02% | -29.2% |
| Q1 2022 | $846,000 | +7.8% | 67,282 | 0.0% | 0.02% | +20.0% |
| Q4 2021 | $785,000 | -12.7% | 67,282 | -2.3% | 0.02% | -13.0% |
| Q3 2021 | $899,000 | -45.4% | 68,853 | -46.2% | 0.02% | -53.1% |
| Q2 2021 | $1,646,000 | +4.9% | 127,867 | -8.9% | 0.05% | +22.5% |
| Q1 2021 | $1,569,000 | +22314.3% | 140,338 | +26229.8% | 0.04% | – |
| Q1 2019 | $7,000 | -99.5% | 533 | -99.4% | 0.00% | -100.0% |
| Q4 2017 | $1,412,000 | +149.9% | 94,200 | +215.1% | 0.11% | +113.2% |
| Q2 2017 | $565,000 | -5.2% | 29,900 | -14.4% | 0.05% | -7.0% |
| Q1 2017 | $596,000 | +69.3% | 34,937 | +51.9% | 0.06% | +32.6% |
| Q4 2016 | $352,000 | -51.6% | 23,005 | -49.7% | 0.04% | -43.4% |
| Q3 2016 | $727,000 | – | 45,758 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |